News from abbvie A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 01, 2015, 16:59 ET

AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc.

 AbbVie Inc. ("AbbVie") (NYSE / CHX / Euronext Paris / SIX: ABBV) today announced that it has extended the expiration of its exchange offer to...

Apr 29, 2015, 08:00 ET

AbbVie to Present at Deutsche Bank 40th Annual Health Care Conference

 AbbVie (NYSE: ABBV) will participate in the Deutsche Bank 40th Annual Health Care Conference on Wednesday, May 6, 2015. Bill Chase, executive...

Apr 25, 2015, 10:00 ET

AbbVie Presents Late-Breaking, Preliminary Phase 3b Data with VIEKIRAX® + EXVIERA® in Chronic Hepatitis C Patients with Renal Impairment at The International Liver Congress™ 2015

AbbVie (NYSE: ABBV) today announced new, preliminary safety and efficacy data from the first cohort of its ongoing, Phase 3b RUBY-I study. RUBY-I...

Apr 24, 2015, 00:45 ET

U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C

 AbbVie (NYSE: ABBV) has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) and granted...

Apr 23, 2015, 15:28 ET

Anvisa aprova VIEKIRA PAK, da AbbVie, para o tratamento de pacientes brasileiros com Hepatite C crônica, Genótipo 1

A Anvisa (Agência Nacional de Vigilância Sanitária) aprovou, em processo de análise prioritária, VIEKIRA PAK (comprimidos...

Apr 23, 2015, 07:48 ET

AbbVie Reports First-Quarter 2015 Financial Results

 AbbVie (NYSE: ABBV) announced financial results for the first quarter ended March 31, 2015. "AbbVie had an exceptional first quarter,...

Apr 17, 2015, 16:47 ET

AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc.

 AbbVie Inc. ("AbbVie") (NYSE / CHX / Euronext Paris / SIX: ABBV) today announced that it has extended the expiration of its exchange offer to...

Apr 15, 2015, 19:00 ET

AbbVie's Investigational Chronic Hepatitis C Treatment Granted Priority Review in Japan

 AbbVie (NYSE: ABBV) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted priority review for its...

Apr 15, 2015, 10:05 ET

AbbVie to Host First-Quarter Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its first-quarter 2015 financial results on Thursday, April 23, 2015, before the market opens. AbbVie will host...

Apr 08, 2015, 04:19 ET

AbbVie to Present New Data from Hepatitis C Clinical Development Program at The International Liver Congress™ 2015

 AbbVie (NYSE: ABBV) today announced that 29 abstracts from its ongoing hepatitis C clinical development program have been accepted for...

Apr 01, 2015, 14:17 ET

AbbVie CF Scholarship Application for Students with Cystic Fibrosis Now Available for 2015-2016 Academic School Year

AbbVie today announced that the 2015 AbbVie CF Scholarship, which honors and supports young adults with cystic fibrosis (CF) as they pursue higher...

Mar 19, 2015, 08:44 ET

AbbVie And C2N Enter Into A Worldwide License Agreement For Alzheimer's Disease Therapy

 AbbVie (NYSE: ABBV) today announced that it has entered into an exclusive worldwide license agreement with C2N Diagnostics, a privately held...

Mar 17, 2015, 16:30 ET

AbbVie inicia, no Brasil, estudos clínicos com novo tratamento para hepatite C, totalmente oral e livre de Interferon

Os pacientes elegíveis para o estudo Topázio III serão os primeiros brasileiros a ter acesso ao tratamento de curta...

Mar 17, 2015, 08:00 ET

AbbVie's Dermatology Leadership Showcased with HUMIRA® (adalimumab) Data at American Academy of Dermatology 2015 Annual Meeting

 AbbVie (NYSE: ABBV) announced that data from 22 abstracts on HUMIRA® (adalimumab) and dermatological diseases will be presented at the...

Mar 06, 2015, 08:00 ET

AbbVie to Present at Barclays Global Health Care Conference

 AbbVie (NYSE: ABBV) will participate in the Barclays Global Health Care Conference on Thursday, March 12, 2015. Richard A. Gonzalez, chairman...

Mar 04, 2015, 22:47 ET

AbbVie to Acquire Pharmacyclics, including its blockbuster product Imbruvica®, Creating an Industry Leading Hematological Oncology Franchise

 AbbVie (NYSE:ABBV) and Pharmacyclics (NASDAQ: PCYC) today announced a definitive agreement under which AbbVie will acquire Pharmacyclics, and...

Feb 26, 2015, 16:48 ET

AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting

 AbbVie (NYSE: ABBV) today announced that 15 abstracts of studies in its neuroscience and oncology development programs have been accepted for...

Feb 26, 2015, 08:00 ET

AbbVie Launches SigueElGuion.com to Educate Spanish-Speaking Americans about Hypothyroidism and the Importance of Dialogue between Patient and Healthcare Professional

 To further awareness about the importance of diagnosing and treating hypothyroidism, a thyroid condition that affects millions of...

Feb 26, 2015, 08:00 ET

AbbVie lanza SigueElGuion.com para instruir a los estadounidenses de habla hispana acerca del hipotiroidismo y la importancia del diálogo entre el paciente y el profesional de la salud

Para aumentar la concientización sobre la importancia de diagnosticar y tratar el hipotiroidismo, una afección de la tiroides que afecta...

Feb 25, 2015, 08:22 ET

AbbVie to Present at Cowen 35th Annual Health Care Conference

AbbVie (NYSE: ABBV) will participate in the Cowen 35th Annual Health Care Conference on Wednesday, March 4, 2015. Bill Chase, executive vice...